Kisspeptin: 5mg

Description

Kisspeptin is a neuropeptide encoded by the kiss1 gene and the most potent known activator of the hypothalamic-pituitary-gonadal (hpg) axis. originally identified as a metastasis suppressor protein — hence the original name “metastin” — its role in reproductive endocrinology was established in 2003 when two independent research teams demonstrated that loss-of-function mutations in its receptor gpr54 (kiss1r) cause idiopathic hypogonadotropic hypogonadism: complete failure of puberty onset despite normal hypothalamic-pituitary anatomy. the most studied research form is kisspeptin-10 (kp-10), the c-terminal decapeptide that retains full receptor potency in a more stable, compact structure. kisspeptin neurons in the arcuate nucleus and anteroventral periventricular nucleus serve as the primary gatekeepers of gnrh pulsatility — they receive and integrate signals from sex steroids, leptin, ghrelin, and metabolic sensors, then generate synchronous pulses that drive the gnrh pulse generator. in male research subjects, a single subcutaneous injection of kp-10 triggers a measurable lh surge within 20–60 minutes, followed by serum testosterone increases within 2 hours. this makes kisspeptin uniquely valuable for hpg axis research: unlike direct lh or gnrh administration, kisspeptin activates the full upstream regulatory cascade without bypassing endogenous feedback. clinical research at imperial college london (dhillo et al. 2005 through comninos et al. 2017) has characterized its dose-response relationship, safety profile, and potential in hypogonadotropic hypogonadism. separate from hpg axis action, fmri studies have documented kisspeptin’s effects on limbic system processing — enhancing amygdala activation during sexual and emotional stimuli independent of any hormonal change. for research and educational purposes only. not fda-approved. consult a qualified healthcare professional.

Specifications

Dose Calculator